Literature DB >> 9027742

Regulation of vascular endothelial growth factor by hypoxia and its modulation by the von Hippel-Lindau tumor suppressor gene.

A P Levy1, N S Levy, O Iliopoulos, C Jiang, W G Kaplin, M A Goldberg.   

Abstract

The regulation of VEGF production is mediated by both transcriptional and post-transcriptional mechanisms. A schematic model of elements involved in hypoxic regulation of VEGF is shown in Figure 1.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9027742     DOI: 10.1038/ki.1997.82

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  19 in total

Review 1.  Oxygen sensing in neuroendocrine cells and other cell types: pheochromocytoma (PC12) cells as an experimental model.

Authors:  Zachary Spicer; David E Millhorn
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

Review 2.  Control of cytokine mRNA expression by RNA-binding proteins and microRNAs.

Authors:  V Palanisamy; A Jakymiw; E A Van Tubergen; N J D'Silva; K L Kirkwood
Journal:  J Dent Res       Date:  2012-02-01       Impact factor: 6.116

Review 3.  The von Hippel-Lindau gene: turning discovery into therapy.

Authors:  Peter E Clark; Michael S Cookson
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

4.  Antagonistic functions of tetradecanoyl phorbol acetate-inducible-sequence 11b and HuR in the hormonal regulation of vascular endothelial growth factor messenger ribonucleic acid stability by adrenocorticotropin.

Authors:  Nadia Cherradi; Cyrille Lejczak; Agnes Desroches-Castan; Jean-Jacques Feige
Journal:  Mol Endocrinol       Date:  2005-11-23

5.  Protective function of von Hippel-Lindau protein against impaired protein processing in renal carcinoma cells.

Authors:  M Gorospe; J M Egan; B Zbar; M Lerman; L Geil; I Kuzmin; N J Holbrook
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

Review 6.  The molecular basis of von Hippel-Lindau disease.

Authors:  O Iliopoulos; W G Kaelin
Journal:  Mol Med       Date:  1997-05       Impact factor: 6.354

7.  Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2.

Authors:  K M Lonergan; O Iliopoulos; M Ohh; T Kamura; R C Conaway; J W Conaway; W G Kaelin
Journal:  Mol Cell Biol       Date:  1998-02       Impact factor: 4.272

8.  Phase II study of erlotinib in patients with locally advanced or metastatic papillary histology renal cell cancer: SWOG S0317.

Authors:  Michael S Gordon; Michael Hussey; Raymond B Nagle; Primo N Lara; Philip C Mack; Janice Dutcher; Wolfram Samlowski; Joseph I Clark; David I Quinn; Chong-Xian Pan; David Crawford
Journal:  J Clin Oncol       Date:  2009-11-02       Impact factor: 44.544

Review 9.  Now a Nobel gas: oxygen.

Authors:  Joachim Fandrey; Johannes Schödel; Kai-Uwe Eckardt; Dörthe M Katschinski; Roland H Wenger
Journal:  Pflugers Arch       Date:  2019-11-22       Impact factor: 3.657

10.  Von Hippel-Lindau gene product modulates TIS11B expression in renal cell carcinoma: impact on vascular endothelial growth factor expression in hypoxia.

Authors:  Sutapa Sinha; Shamit Dutta; Kaustubh Datta; Asish K Ghosh; Debabrata Mukhopadhyay
Journal:  J Biol Chem       Date:  2009-09-28       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.